Ayala Pharmaceuticals, Inc. Annual Depreciation in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Ayala Pharmaceuticals, Inc. annual/quarterly Depreciation history and growth rate from 2010 to 2023.
  • Ayala Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2023 was $44K, a 46.7% increase year-over-year.
  • Ayala Pharmaceuticals, Inc. annual Depreciation for 2023 was $334K, a 106% increase from 2022.
  • Ayala Pharmaceuticals, Inc. annual Depreciation for 2022 was $162K, a 58.1% decline from 2021.
  • Ayala Pharmaceuticals, Inc. annual Depreciation for 2021 was $387K, a 56.9% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $334K +$172K +106% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2022 $162K -$225K -58.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 $387K -$510K -56.9% Nov 1, 2020 Oct 31, 2021 10-K 2023-02-10
2020 $897K -$200K -18.2% Nov 1, 2019 Oct 31, 2020 10-K 2022-02-14
2019 $1.1M -$16K -1.44% Nov 1, 2018 Oct 31, 2019 10-K 2021-01-22
2018 $1.11M +$322K +40.7% Nov 1, 2017 Oct 31, 2018 10-K 2019-12-20
2017 $791K +$507K +179% Nov 1, 2016 Oct 31, 2017 10-K 2019-01-11
2016 $284K +$225K +380% Nov 1, 2015 Oct 31, 2016 10-K 2017-12-21
2015 $59K +$31.4K +114% Nov 1, 2014 Oct 31, 2015 10-K 2017-12-21
2014 $27.6K +$8.31K +43.1% Nov 1, 2013 Oct 31, 2014 10-K 2017-01-09
2013 $19.3K +$5.52K +40.1% Nov 1, 2012 Oct 31, 2013 10-K 2015-01-06
2012 $13.8K -$14.6K -51.5% Nov 1, 2011 Oct 31, 2012 10-K 2014-01-29
2011 $28.4K -$10.1K -26.3% Nov 1, 2010 Oct 31, 2011 10-K/A 2013-02-14
2010 $38.5K Nov 1, 2009 Oct 31, 2010 10-K 2012-01-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.